Please ensure Javascript is enabled for purposes of website accessibility

Why DexCom Shares Are Flying Higher Today

By Keith Speights - Feb 14, 2020 at 11:06AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors loved the medical device maker's great Q4 results.

What happened

Shares of DexCom (DXCM 3.27%) were flying 15.4% higher as of 11:44 a.m. EST on Friday. The big gain came following the company's announcement of its 2019 fourth-quarter and full-year results after the market closed on Thursday.

DexCom reported Q4 revenue of $462.8 million, up 37% year over year and well above the average analysts' estimate of $442.4 million. It also announced adjusted earnings of $106.5 million, or $1.15 per share. This reflected significant improvement from adjusted earnings of $50.2 million, or $0.56 per share, posted in the prior-year period. It also blew past the consensus Wall Street earnings estimate of $0.74 per share. 

Red line going up with a rocket flying above the line

Image source: Getty Images.

So what

When a company beats estimates the way DexCom did with its Q4 results, its stock is bound to jump. The key question to ask, though, is: Why did the company top estimates?

In DexCom's case, the answer is simple. The company's G6 continuous glucose monitoring (CGM) systems continue to enjoy strong customer demand. And that strong demand isn't just in the U.S. DexCom's international sales grew even faster than its U.S. sales did in the fourth quarter.

This momentum seems likely to continue. Diabetes remains a serious problem across the world. Real-time CGM offers a way for patients to keep their diabetes under control.

Now what

DexCom's nice jump today probably won't fade away. The company projects strong full-year 2020 revenue growth. With sales for the G6 device soaring and a new G7 CGM coming in the future, DexCom appears to be one of the most promising healthcare stocks on the market.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

DexCom, Inc. Stock Quote
DexCom, Inc.
DXCM
$77.67 (3.27%) $2.46

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.